Cancer in 2025: Funding, New Treatments, and Breakthrough Ideas
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
For World Cancer Research Day, AACR convened a panel of experts to discuss how they are helping to drive...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Recent advances in the genomics of childhood cancer may help inform potential causes and better treatment strategies.
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.